Clinical Trials
23 trialsNCT05502367 2026-02-19
A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia
Antiva Biosciences
Phase 1/2 Terminated
NCT06086054 2025-08-05
Effect of a Childcare Resource on Cervical Cancer Prevention
University of Texas Southwestern Medical Center
Phase NA Terminated
NCT02140021 2025-07-14
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
M.D. Anderson Cancer Center
Phase NA Terminated
NCT04278326 2025-04-20
ORGANOIDES
Centre Hospitalier Régional d'Orléans
Phase NA Terminated
NCT03267680 2025-04-13
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
University of Southern California
Phase 2 Terminated
NCT02574442 2024-03-18
Confocal
British Columbia Cancer Agency
Terminated
NCT03285841 2024-03-18
OCT-AF Imaging of Pre-cancers of Vulva and Cervix
British Columbia Cancer Agency
Terminated
NCT00577317 2021-06-23
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
GOG Foundation
Phase 3 Terminated
NCT00519272 2020-01-02
A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients
M.D. Anderson Cancer Center
Terminated
NCT02329171 2018-08-15
TOPIC
Maastricht University Medical Center
Phase 3 Terminated
NCT00004261 2018-02-22
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
University Health Network, Toronto
Phase 1 Terminated
NCT00278434 2017-11-24
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
University of California, San Francisco
Phase 1 Terminated
NCT00629577 2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1 Terminated
NCT01283763 2016-11-01
ITIC2
Medical University of Vienna
Phase 3 Terminated
NCT00312286 2016-09-23
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Takeda
Phase 2 Terminated
NCT00117884 2016-08-19
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Takeda
Phase 2 Terminated
NCT01116245 2016-07-27
ADXS11-001
Advaxis, Inc.
Phase 2 Terminated
NCT00529464 2016-05-09
Spectroscopy Versus Standard Care in Cervical Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00233727 2015-07-09
SAT
Columbia University
Phase 3 Terminated
NCT00682552 2014-08-28
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
Assistance Publique Hopitaux De Marseille
Phase NA Terminated
NCT00708942 2013-04-24
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Photocure
Phase 2 Terminated
NCT00005808 2013-02-07
Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00511758 2012-08-01
Digital Imaging Aid for Assessment of Cervical Dysplasia
M.D. Anderson Cancer Center
Terminated